Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus.

Shetty S, Stafkey-Mailey D, Yue B, Coutinho AD, Wang W, Del Parigi A, Sander SD, Coleman CI.

Curr Med Res Opin. 2018 Jun;34(6):1081-1087. doi: 10.1080/03007995.2018.1445620. Epub 2018 Mar 29.

PMID:
29480076
2.

Incremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations.

Coutinho AD, Raju AD, Wang W, Stafkey-Mailey D, Shetty S, Sander SD.

Curr Med Res Opin. 2018 Jun;34(6):1005-1012. doi: 10.1080/03007995.2018.1434497. Epub 2018 Feb 16.

PMID:
29378486
3.

Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis.

Correll CU, Ng-Mak DS, Stafkey-Mailey D, Farrelly E, Rajagopalan K, Loebel A.

Ann Gen Psychiatry. 2017 Feb 10;16:9. doi: 10.1186/s12991-017-0133-7. eCollection 2017.

4.

Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA.

Mytelka DS, Li L, Stafkey-Mailey D, Liepa AM, Hess LM, Farrelly E, Eaddy M.

Hematology. 2014 Dec 31. [Epub ahead of print]

PMID:
25551431
5.

Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.

O'Day K, Meyer K, Stafkey-Mailey D, Watson C.

J Med Econ. 2015 Apr;18(4):295-302. doi: 10.3111/13696998.2014.991786. Epub 2014 Dec 10.

PMID:
25422991
6.

Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics.

Rouleau A, Guiraud-Diawara A, Landsman-Blumberg P, Lokhandwala T, Stafkey-Mailey D, Verpillat P.

Value Health. 2014 Nov;17(7):A577. doi: 10.1016/j.jval.2014.08.1946. Epub 2014 Oct 26. No abstract available.

7.

Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.

Qureshi ZP, Norris L, Sartor O, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL.

J Oncol Pract. 2012 Mar;8(2):84-90. doi: 10.1200/JOP.2011.000325. Epub 2011 Dec 13.

8.

Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.

Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M.

Psychiatr Serv. 2011 Sep;62(9):1032-40. doi: 10.1176/appi.ps.62.9.1032.

PMID:
21885581
9.

Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics.

Marshall TS, McCombs JS, Stafkey-Mailey D.

Value Health. 2009 Jun;12(4):473-80. doi: 10.1111/j.1524-4733.2008.00458.x. Epub 2008 Sep 16.

10.

Adherence to medications by patients after acute coronary syndromes.

Sud A, Kline-Rogers EM, Eagle KA, Fang J, Armstrong DF, Rangarajan K, Otten RF, Stafkey-Mailey DR, Taylor SD, Erickson SR.

Ann Pharmacother. 2005 Nov;39(11):1792-7. Epub 2005 Oct 4.

PMID:
16204391

Supplemental Content

Loading ...
Support Center